ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,016.33
      0.07%
      US Tech 100
      20,578.80
      0.05%
      Dow Jones
      44,778.62
      0.15%
      Brent Oil
      76.665
      0.52%
      Bitcoin
      102,658.69
      0.58%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. AcelRX Pharmaceuticals Inc (ACRX) Quote

      AcelRX Pharmaceuticals Inc

      AcelRX Pharmaceuticals Inc (ACRX)

      NASDAQ
      0.86
      0.00
      (0.00%)
      Closed January 27 4:00PM
      Delayed by 15 minutes
      0.86
      0.00
      ( 0.00% )
      Pre Market: 7:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.86
      Bid
      0.861
      Ask
      0.89
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      14.579M
      Previous Close
      0.86
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      16,952,000
      Dividend Yield
      -
      PE Ratio
      -0.66
      Earnings Per Share (EPS)
      -1.09
      Revenue
      651k
      Net Profit
      -18.4M

      About AcelRX Pharmaceuticals Inc

      AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      talphera.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      ACRX Latest News

      More News

      FeaturedLaFleur Minerals Provides Updates on Exploration at Swanson Gold Deposit and Plans to Restart of Beacon Gold Mill

      24 hours ago

      Form 4 - Statement of changes in beneficial ownership of securities

      June 24 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 24 2024
      Edgar (US Regulatory)

      Form ARS - Annual Report to Security Holders

      April 29 2024
      Edgar (US Regulatory)

      Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

      April 29 2024
      Edgar (US Regulatory)

      Form DEF 14A - Other definitive proxy statements

      April 29 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      April 19 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      March 21 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      March 15 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      March 12 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      ACRX - Frequently Asked Questions (FAQ)

      What is the current AcelRX Pharmaceuticals share price?
      The current share price of AcelRX Pharmaceuticals is $ 0.86
      How many AcelRX Pharmaceuticals shares are in issue?
      AcelRX Pharmaceuticals has 16,952,000 shares in issue
      What is the market cap of AcelRX Pharmaceuticals?
      The market capitalisation of AcelRX Pharmaceuticals is USD 14.58M
      What is the 1 year trading range for AcelRX Pharmaceuticals share price?
      AcelRX Pharmaceuticals has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of AcelRX Pharmaceuticals?
      The price to earnings ratio of AcelRX Pharmaceuticals is -0.66
      What is the cash to sales ratio of AcelRX Pharmaceuticals?
      The cash to sales ratio of AcelRX Pharmaceuticals is 18.75
      What is the reporting currency for AcelRX Pharmaceuticals?
      AcelRX Pharmaceuticals reports financial results in USD
      What is the latest annual turnover for AcelRX Pharmaceuticals?
      The latest annual turnover of AcelRX Pharmaceuticals is USD 651k
      What is the latest annual profit for AcelRX Pharmaceuticals?
      The latest annual profit of AcelRX Pharmaceuticals is USD -18.4M
      What is the registered address of AcelRX Pharmaceuticals?
      The registered address for AcelRX Pharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
      What is the AcelRX Pharmaceuticals website address?
      The website address for AcelRX Pharmaceuticals is talphera.com
      Which industry sector does AcelRX Pharmaceuticals operate in?
      AcelRX Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AALAmerican Airlines Group Inc
      $ 17.20
      (0.00%)
      		135.2k
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 73.00
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 3.00
      (0.00%)
      		221
      AACGATA Creativity Global
      $ 0.8301
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 17.20
      (0.00%)
      		135.2k
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 73.00
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 3.00
      (0.00%)
      		221
      AACGATA Creativity Global
      $ 0.8301
      (0.00%)
      		0
      TRIBTrinity Biotech PLC
      $ 0.76
      (0.00%)
      		55.11M
      SLXNSilexion Therapeutics Corporation
      $ 0.58
      (0.00%)
      		38.56M
      BACKIMAC Holdings Inc
      $ 0.829
      (0.00%)
      		35.15M
      HEPAHepion Pharmaceuticals Inc
      $ 0.165
      (0.00%)
      		34.4M
      NVDANVIDIA Corporation
      $ 118.42
      (0.00%)
      		27.49M

      Discussion

      View Full Feed
      misterfishman misterfishman 2 minutes ago
      you will see our stock shooting to the moon.
      IGPK
      DrHigh DrHigh 2 minutes ago
      I always knew he was a bear in clown's clothing. A clown bear though so it wasn't much of a stretch really
      NWBO
      pos_stock_hoarder pos_stock_hoarder 2 minutes ago
      https://assets.amuniversal.com/10760930ba51013d8ae0005056a9545d
      getmoreshares getmoreshares 2 minutes ago
      approx 5m opening vol
      NBRI
      ProfitChaser ProfitChaser 3 minutes ago
      WOW. Impressive. Great DD
      $b_rich$ $b_rich$ 3 minutes ago
      You're welcome and yes, the float is fantastic:)
      Stock_Barber Stock_Barber 4 minutes ago
      BANT is a scam... I could care less about P&D's!

      You may laugh while driving by a sign that says "Falling Rocks"... but the sign is there for a reason!

      https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fthumbs.dreamstime.com%2Fb%2Ffalling-rocks-50030210.jpg&
      BANT
      sab63090 sab63090 4 minutes ago
      ignatius

      They carry short inventory for short term and long term, but I get your point!

      The chief trader looks at the assigned trader's short term trading efforts:gains & losses and bonuses are made up from that; normally he is directed on the longer held positions fr
      AVXL
      nssrr5 nssrr5 4 minutes ago
      I agree - I am 55 and been holding for a couple years but I hope this hits before I dead LOL. I never thought it could get this low and I am not sure how it will hold above a dollar with the shorts in control and an administration that will do nothing for cannabis....

      Good Luck
      TLRY
      Spicoli Spicoli 4 minutes ago
      Matt Taibbi @mtaibbi and Tucker Carlson@TuckerCarlson should talk about this.
      https://x.com/TuckerCarlson/status/1883939641499258998
      FNMA
      dexprs dexprs 5 minutes ago
      Placing a few Buy to Close Call orders, since this could be a good day for them.
      SeaBlue SeaBlue 5 minutes ago
      Wonder if and/or how much this will impact markets today:
      https://justthenews.com/government/federal-agencies/trump-administration-freezes-federal-aid-outside-social-security-and
      FFMGF
      katiesdad7 katiesdad7 5 minutes ago
      After having google AI look at this stock February 16th is the day it predicted the next update. I didn't know it was the 4th anniversary. 

      Go figure. 
      CBRF
      getmoreshares getmoreshares 5 minutes ago
      Held at DTC 1,612,365,645 01/09/2025
      https://www.otcmarkets.com/stock/KATX/security
      KATX
      doc2016 doc2016 6 minutes ago
      interesting, articles are saying the deepseek ai is designed to run on a laptop...just at a time nvidia is going to release a mini supercomputer for same purpose? also, of note is the requirement for nvidia inference chip component of the generative ai process. now verizon connect ai enters...cli
      glens0 glens0 6 minutes ago
      Thank you
      CTOR
      TheRealMrPirate TheRealMrPirate 6 minutes ago
      Sorry, there is no BioAmber and there are no shares any longer.
      Nice fantasy though. 🦄

      https://investorshub.advfn.com/uimage/uploads/2024/12/8/ctxpaAwwh-BIOAQ-Final.JPG

      https://investorshub.advfn.com/uimage/uploads/2024/4/3/jiyrmBiowin.PNG
      glenn1919 glenn1919 7 minutes ago
      MULN..................................................................................................smackthatbottom............................https://stockcharts.com/h-sc/ui?s=muln&p=D&yr=0&mn=2&dy=12&id=p84071410134
      MULN
      Number sleven Number sleven 7 minutes ago
      https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/variations-including-extensions-marketing-authorisations/type-ii-variations-questions-answers
      Sleven,
      AMRN
      RIGATONI RIGATONI 7 minutes ago
      Nice volume on...

      HEPA .218


      could see further traction, hit .265 area early market
      HEPA
      Mrt33 Mrt33 7 minutes ago
      Bottom feeder
      INKW
      Mrt33 Mrt33 7 minutes ago
      You do your best at conning people.
      INKW
      Fallingknife75 Fallingknife75 7 minutes ago
      Yet here you are, hmm.

      Knife
      NBRI
      SeaBlue SeaBlue 8 minutes ago
      Me too. EOM
      FFMGF
      biowin biowin 8 minutes ago
      This is very interesting should be the same with Bioamber shares and KKR fund
      https://www.stocktitan.net/news/INSI/insight-select-income-fund-announces-results-of-special-meeting-of-ba54x9adi7xh.html

      Your Recent History

      NASDAQ
      ACRX
      AcelRX Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads